The Syneos Health Podcast

NEWYORKBIO BIOPHARMA INNOVATORS SERIES: Taming the Healthcare Data Explosion

May 15, 2020 Jeffrey Stewart and Marc Berger
The Syneos Health Podcast
NEWYORKBIO BIOPHARMA INNOVATORS SERIES: Taming the Healthcare Data Explosion
Chapters
The Syneos Health Podcast
NEWYORKBIO BIOPHARMA INNOVATORS SERIES: Taming the Healthcare Data Explosion
May 15, 2020
Jeffrey Stewart and Marc Berger

In this episode in our Biopharma Innovators Series in partnership with NewYorkBIO, we feature a leader in the field of real world data and outcomes research.

Marc Berger, MD, Head of the Real World Evidence Product Advisory Board for SHYFT Analytics and former Vice President of Real World Data and Analytics at Pfizer, discusses the double-edged sword inherent in the veritable mountain of data available to us, from issues of privacy and accessibility of data to how companies can query this data in order to efficiently and effectively glean the insights they need.

Stay tuned for more of our weekly Biopharma Innovators Series, where you’ll hear New York-based industry experts on a wide range of important issues, from helping patients navigate clinical trials, to real world evidence and value for innovation, to bringing lower priced drugs to market, and more. And to catch some of these experts live and in person, be sure to register for the rescheduled NewYorkBIO 2020 Annual Meeting on September 14th!

If you want access to more future-focused, actionable insights to help biopharmaceutical companies better execute and succeed in a constantly evolving environment, visit the Syneos Health Insights Hub. The perspectives you’ll find there are driven by dynamic research and crafted by subject matter experts focused on real answers to help guide decision making and investment. You can find it all at insightshub.health.

Like what you’re hearing?  Be sure to rate and review us!  

We want to hear from you!  If there’s a topic you’d like us to cover on a future episode, contact us at [email protected]

Show Notes

In this episode in our Biopharma Innovators Series in partnership with NewYorkBIO, we feature a leader in the field of real world data and outcomes research.

Marc Berger, MD, Head of the Real World Evidence Product Advisory Board for SHYFT Analytics and former Vice President of Real World Data and Analytics at Pfizer, discusses the double-edged sword inherent in the veritable mountain of data available to us, from issues of privacy and accessibility of data to how companies can query this data in order to efficiently and effectively glean the insights they need.

Stay tuned for more of our weekly Biopharma Innovators Series, where you’ll hear New York-based industry experts on a wide range of important issues, from helping patients navigate clinical trials, to real world evidence and value for innovation, to bringing lower priced drugs to market, and more. And to catch some of these experts live and in person, be sure to register for the rescheduled NewYorkBIO 2020 Annual Meeting on September 14th!

If you want access to more future-focused, actionable insights to help biopharmaceutical companies better execute and succeed in a constantly evolving environment, visit the Syneos Health Insights Hub. The perspectives you’ll find there are driven by dynamic research and crafted by subject matter experts focused on real answers to help guide decision making and investment. You can find it all at insightshub.health.

Like what you’re hearing?  Be sure to rate and review us!  

We want to hear from you!  If there’s a topic you’d like us to cover on a future episode, contact us at [email protected]